Finance

Lists
Q1 2027 earnings • released • EPS miss -13.54% • Revenue beat +2.24%
See results
EMAMILTD:NSE
Emami Ltd
₹403.20
+0.21%
(+0.85) 1D
Aug 6, 1:16:05 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for EMAMILTD...
Open
₹403.00
High
₹407.00
Low
₹402.95
Mkt. cap
176.00B
Avg. vol.
645.70K
Volume
186.02K
Dividend
2.48%
Quarterly dividend
₹2.50
Ex-dividend date
Feb 10, 2026
P/E ratio
22.70
52-wk high
₹634.20
52-wk low
₹376.40
EPS
₹17.76
Shares outstanding
453.94M
No. of employees
3K
Open
₹403.00
High
₹407.00
Low
₹402.95
Mkt. cap
176.00B
Avg. vol.
645.70K
Volume
186.02K
Dividend
2.48%
Quarterly dividend
₹2.50
Ex-dividend date
Feb 10, 2026
P/E ratio
22.70
52-wk high
₹634.20
52-wk low
₹376.40
EPS
₹17.76
Shares outstanding
453.94M
No. of employees
3K
News stories
From sources across the web
Profile
Emami Group is an Indian multinational conglomerate headquartered in Kolkata. The company caters to a number of niche categories in the personal care and healthcare segments. The company's products are sold across 60+ nations and are available in 4.5 million retail outlets across India. The company has seven manufacturing units across India and one overseas unit. Among its prominent brands is an antiseptic cream named BoroPlus. The company's skin care division generated an overall revenue of ₹2,655 crores in the financial year 2019–20 with an annual profit of ₹639 crores. The total group revenue of the company stands at ₹20,000 crores. Wikipedia
About Emami Ltd
CEOSudhakar Rao Desai
Employees3.1K
Founded1974
Headquarters-
SectorPersonal care products
Websiteemamiltd.in
Last report
Aug 4, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹3.46 / ₹4.00
-13.54%miss
Revenue / Est. (INR)
10.39B / 10.16B
+2.24%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
9.04B
7.99B
11.52B
9.25B
Cost of goods sold
2.76B
2.31B
3.38B
3.31B
Cost of revenue
2.76B
2.31B
3.38B
3.31B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.99B
2.78B
3.13B
3.42B
Operating expense
4.58B
4.34B
4.75B
4.43B
Total operating expenses
7.34B
6.65B
8.13B
7.74B
Operating income
1.70B
1.33B
3.39B
1.51B
Other non operating income
215.90M
213.70M
189.70M
-592.95M
EBT including unusual items
1.87B
1.50B
3.45B
1.64B
EBT excluding unusual items
1.87B
1.50B
3.55B
1.21B
Income tax expense
225.10M
18.30M
255.70M
208.99M
Effective tax rate
12.05%
1.22%
7.41%
12.74%
Other operating expenses
1.14B
1.11B
1.17B
588.30M
Net income
1.64B
1.48B
3.19B
1.43B
Net profit margin
18.17%
18.58%
27.74%
15.48%
Earnings per share
4.22
3.92
7.54
3.67
Interest and investment income
-
-
-
321.25M
Interest expense
-24.30M
-26.30M
-29.20M
-31.50M
Net interest expenses
-24.30M
-26.30M
-29.20M
289.75M
Depreciation and amortization charges
217.20M
222.30M
222.80M
226.62M
EBITDA
2.10B
1.74B
3.79B
1.91B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps